Showing posts with label Healthcare Market Research Reports. Show all posts
Showing posts with label Healthcare Market Research Reports. Show all posts

Thursday, 26 July 2012

Clinical Laboratory Testing Volume 1: IVD Reagents and Instruments Markets

Clinical laboratory in vitro diagnostic (IVD) testing for reagent and instrument sales is one of the most important sectors of medical care. By all accounts, it is a very mature, large market employing over 100,000 laboratory workers and spawning an industry for reagents and instruments comprised of thousands of companies worldwide. The term clinical laboratory testing usually refers to determining the concentration or activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small molecule in easily collected body fluids such as blood, serum, plasma or urine. However, it is not necessarily limited to these determinations. The purpose of this TriMark Publications report is to describe the specific segments of the global clinical laboratory instrumentation and reagent market. Within this area, the report covers segments that are highly active in terms of innovation and growth. Specifically, this clinical laboratory testing report examines the markets for small lab equipment all the way up to highly-automated, large lab platforms, as well as accessory equipment such as reagents, supplies and manufacturers' original equipment manufacturer (OEM) additional equipment. The emphasis is on companies and products that are actively developing and marketing laboratory analyzer products for the clinical setting, including hospitals, independent labs, physician's offices and miscellaneous clinics. This study concentrates on the clinical laboratory instrumentation industry market segment and the companion reagents sector in the U.S. and around the world. The regional markets and their differences are examined, including in Europe, Asia (Japan, China and India) and the rest of the world (ROW).

Buy your copy of this report @ http://www.reportsnreports.com/reports/181583-clinical-laboratory-testing-volume-1-ivd-reagents-and-instruments-markets.html


Report Details:
Published: July 2012
No. of Pages: 279
Price: Single User License – US$3400             Corporate User License – US$6800





Table of Contents

1. Overview 8
1.1 Objectives of the Report 8
1.2 Methodology 9
1.3 Scope of the Report 10
1.4 Executive Summary 11

2. IVD Industry 19
2.1 Industry Overview 19
2.2 IVD Industry Leading Players Comparison and Review 19
2.2.1 Roche Diagnostics 20
2.2.2 Abbott Laboratories 22
2.2.3 Siemens Healthcare Diagnostics 25
2.2.4 Becton, Dickinson & Co. 26
2.2.5 Beckman Coulter, Inc. 26
2.2.6 Ortho-Clinical Diagnostics 31
2.2.7 bioMérieux 32
2.2.8 Sysmex 32
2.2.9 Bio-Rad Laboratories, Inc. 32
2.2.10 ARKRAY, Inc. 33
2.2.11 Cytyc Corporation (A Hologic Company) 33
2.2.12 Gen-Probe, Inc. 33
2.3 Biotechnology Reagents and Supplies 34
2.3.1 Vendor Quality Assurance 36
2.3.2 Partnership Support 36
2.3.3 Protecting Supply of Raw Materials 37
2.3.4 Selecting a Second Source for Chemicals 38
2.3.5 Cost Analysis for Reagent Manufacture 39
2.3.6 Outsourcing Production of Reagents 39
2.4 The Fastest Growing IVD Reagent Markets 39
2.5 High Growth Applications Spur Industry Growth 40
2.6 Automated Instrument Platforms Evolution 41
2.7 Reagents and Supplies Market for Clinical Lab Instruments 41
2.8 Spending for Clinical Laboratory Testing 41
2.8.1 Reimbursement Pressure 42
2.8.2 Medicare Part B Spending Trends 43
2.8.3 Strategies for Revenue Growth 45
2.8.4 Electronic Health Records 45

3. IVD Clinical Laboratory Instrument and Reagent Market 46
3.1 Markets 46
3.1.1 Global Markets 46
3.1.2 Global Drivers of Clinical Laboratory Testing 48
3.1.3 Global Outlook 49
3.1.4 U.S. Market 50
3.1.5 European IVD Instruments and Reagents Market 54
3.1.5.1 German Clinical Laboratory Diagnostic Markets 63
3.1.5.2 U.K. Clinical Laboratory Testing Diagnostic Product Market 65
3.1.5.2.1 U.K. Competitive Analysis 65
3.1.5.2.2 U.K. Market Access 67
3.1.5.3 French Clinical Laboratory Diagnostic Testing Products Market 67
3.1.5.4 Italian Clinical Laboratory Diagnostic Products Market 68
3.1.5.5 Spanish Clinical Laboratory Diagnostic Market 69
3.1.5.6 Finnish Clinical Laboratory Products Market 70
3.1.5.7 Turkish Clinical Laboratory Products Market 71
3.1.5.8 Belgium Clinical Laboratory Diagnostic Products Market 72
3.1.5.9 Swiss Clinical Laboratory Diagnostic Products Market 72
3.1.5.10 Dutch Clinical Laboratory Diagnostic Products Market 73
3.1.5.11 Portuguese Clinical Laboratory Diagnostic Products Market 73
3.1.5.12 Austrian Clinical Laboratory Diagnostic Products Market 74
3.1.5.13 Greek Clinical Laboratory Diagnostic Products Market 75
3.1.5.14 Polish Clinical Laboratory Diagnostic Products Market 75
3.1.5.15 Romanian Clinical Laboratory Diagnostic Products Market 76
3.1.5.16 Czech Republic Clinical Laboratory Diagnostic Products Market 77
3.1.5.17 Swedish Clinical Laboratory Diagnostic Products Market 77
3.1.5.18 Norwegian Clinical Laboratory Diagnostic Products Market 78
3.1.5.19 Irish Clinical Laboratory Diagnostic Products Market 78
3.1.5.20 Hungarian Clinical Laboratory Diagnostic Products Market 79
3.1.5.21 Bulgarian Clinical Laboratory Diagnostic Products Market 79
3.1.5.22 Slovakian Clinical Laboratory Diagnostic Products Market 80
3.1.5.23 Lithuanian Clinical Laboratory Diagnostic Products Market 81
3.1.5.24 Latvian Clinical Laboratory Diagnostic Products Market 81
3.1.5.25 Estonian Clinical Laboratory Diagnostic Products Market 82
3.1.5.26 Slovenian Clinical Laboratory Products Diagnostic Market 82
3.1.5.27 Russian Clinical Laboratory Diagnostic Products Market 83
3.1.6 Asian Markets 83
3.1.6.1 Indian Clinical Laboratory Diagnostic Products Market 85
3.1.6.1.1 Indian IVD Testing Instrument and Reagents Industry 85
3.1.6.2 Japanese Clinical Laboratory Testing Products Market 91
3.1.6.3 Chinese Clinical Laboratory Instrument and Reagent Market 92
3.1.7 Clinical Laboratory Smaller Country Markets 103
3.1.7.1 Canadian Clinical Laboratory Market 103
3.1.7.2 Brazilian Clinical Laboratory Instrument and Reagent Market 103
3.1.7.3 Australian Clinical Laboratory Instrument and Reagent Market 105
3.1.8 ROW Clinical Laboratory Testing Instrument and Reagent Market 105
3.1.9 Overview of Asian Clinical Laboratory Instrument and Reagent Market 106
3.1.9.1 Singapore 107
3.1.9.2 Malaysia 109
3.1.9.3 Thailand 109
3.1.9.4 Indonesia 110
3.1.9.5 Philippines 110
3.1.9.6 South Korea 110
3.1.9.7 India 111
3.1.9.8 Hong Kong 111
3.1.9.9 Taiwan 111
3.1.10 Overview of the Latin American Diagnostics Market 112
3.2 Clinical Laboratory Sector 113
3.2.1 Key Industry Players 113
3.2.2 Market Specialization 116
3.2.3 Revenue and Reimbursement 118
3.2.4 Companies 119
3.3 Outlook for Clinical Laboratory Testing 120
3.3.1 Long-term Changes 120
3.3.2 Market Drivers 121
3.3.3 The Limits to Growth 123
3.3.4 Hot Sectors in the IVD Market 123
3.3.5 Key Technologies 125
3.3.6 Conclusion 125

Browse reports related to Healthcare @ http://www.reportsnreports.com/market-research/healthcare/

Wednesday, 14 March 2012

Regional Overview - Consumer Health Trends in Asia Pacific

This report examines the size, growth trends and potential opportunities in the Consumer Health market. The strategic analyses include assessing the impacts of changing regulations, research breakthroughs and public health concerns on both the market and leading companies.  Consumer attitudes towards the products and their personal healthcare needs are also explored.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Asia Pacific Consumer Health Market

Published: March 2012
No. of Pages: 59
Price: US$2000 
 
Request Sample
Asia Pacific continues to deliver a wealth of growth prospects for consumer health companies and organisations. A large consumer base and untapped demand for self-care options create significant expansion opportunities for domestic, regional and multinational companies. However, regulatory hurdles, patent litigation and east versus west cultural differences pose important challenges to gaining access to the largest region in the world.

Why buy this report?
•    Get a detailed picture of the Consumer Health market;
•    Pinpoint growth sectors and identify factors driving change;
•    Understand the competitive environment, the market’s major players and leading brands;
•    Use five-year forecasts to assess how the market is predicted to develop.

Major points covered in Table of Contents of this report include:
Introduction
Asia Pacific Performance
Drivers of Consumer Health Demand
The Future of Consumer Health in Asia Pacific
Report Definitions

Explore reports related to Healthcare @ http://www.reportsnreports.com/market-research/healthcare/                                                    

Wednesday, 11 January 2012

Global Markets for Devices for Treating Congestive Heart Failure -- Focus on the Americas


• The global market for congestive heart failure devices was $3.1 billion in 2010. This global market reached $3.4 billion in 2011 and is expected to grow to $5.9 billion by 2016, a compound annual growth rate (CAGR) of 11.7%.
• The American market for congestive heart failure devices accounted for nearly 52.5% of the market in 2010 and was valued at $1.6 billion. This market is expected to reach $1.8 billion in 201 and BCC anticipates that the market will approach $3.2 billion by 2016, a CAGR of 12.4%.
• In the Americas, ventricular assist devices (VAD) were the leading revenue generator with $761.5 million in 2011 and an expected $1.3 billion in 2016. VADs secured 43% of the market in 2011 and will continue to command 42% market share in 2016.

STUDY GOALS AND OBJECTIVES
The objectives of the study are to present a comprehensive look at the devices for treating congestive heart failure (CHF)  provide global market measurements of both the overall market and all possible market segments, and to forecast market and segment growth over the next 5 years.  This is the second report in the complete coverage of congestive heart failure.  The first report, Drugs for Treating Congestive Heart Failure:  Global Markets, is available from BCC Research.

Congestive Heart Failure Treatment Device Market

Published: January 2012
No. of Pages: 97
Price: Single User License – US$3900              Corporate User License – US$6835

                                      

REASONS FOR STUDY
This BCC study is presented to increase the awareness of devices to treat congestive heart failure.  The study analyzes select devices for treating the congestive heart failure  global market from different standpoints and addresses issues and trends affecting the market.  Congestive heart failure drug manufacturers, driven by both research breakthroughs and increased recognition of expanding market opportunities, have stepped up the pace of development of innovative products.  Because of the evolving nature of this important area of study, executives of product development for congestive heart failure devices must remain ever vigilant of the changing environment and strive to keep abreast of new and currently used modalities in all facets of the market.

SCOPE OF STUDY
This report is a comprehensive business tool designed to provide an in-depth look at devices for the congestive heart failure market.  The geographic scope of the report is global with a special emphasis on individual regions.  The report describes the industry, its relationship to the healthcare industry and its participants, and trends for the future.

Categories discussed in the report include:
• Ventricular Assist Devices        
• Implantable Cardioverter Defibrillators
• Pacemakers
• Others and Total Artificial Hearts.  

All categories are discussed in detail, describing each segment, identifying current products on the market, measuring market size, identifying market drivers, forecasting for 2011 to 2016, and assessing the competitors and competitor market shares.

Explore Tables of Contents available in the report http://www.reportsnreports.com/reports/144585-global-markets-for-devices-for-treating-congestive-heart-failure-focus-on-the-americas.html.



Tuesday, 13 September 2011

European Point of Care Diagnostic Testing Markets

Published: September 2011
No. of Pages: 179
Price: $ 3400


Point of care testing (POCT) enables diagnostic tests to be performed rapidly while the patient remains at the point of care facility, such as a hospital, health clinic, doctor's office or another near-patient venue. POCT is rapidly being recognized as a method of providing the results of the diagnostic tests immediately, rather than waiting hours or even days for outside lab results to arrive, thus improving patient outcomes. This report analyzes the European market for POCT products, a major component of the overall European in vitro diagnostics (IVD) category. This study reviews in detail the key sub-segments of the point of care diagnostics market including: blood glucose, blood gas and electrolytes, rapid coagulation, cardiac markers, substance abuse, infectious diseases, urine strip, pregnancy, fecal occult, cholesterol, and many others. For each of the individual sub-segments, this study examines the key market drivers and restraints, as well as evaluates the latest technological advances. 


The key feature of the review is a detailed analysis of the revenues, market growth rates and market share for the European market and for each of the selected geographic regions, which include: France, Germany, Italy, Spain, the U.K., the Benelux countries, Scandinavia and the Rest of Europe (ROE). The analysis surveys almost all of the companies known to be marketing, manufacturing or developing instruments and reagents for the point of care market in the European market. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market data are also included.